Literature DB >> 1280334

Primary structure and functional characterization of a high-affinity glutamate transporter.

Y Kanai1, M A Hediger.   

Abstract

Glutamate transport across plasma membranes of neurons, glial cells and epithelial cells of the small intestine and kidney proceeds by high- and low-affinity transport systems. High-affinity (Km 2-50 microM) transport systems have been described that are dependent on Na+ but not Cl- ions and have a preference for L-glutamate and D- and L-aspartate. In neurons high-affinity glutamate transporters are essential for terminating the postsynaptic action of glutamate by rapidly removing released glutamate from the synaptic cleft. We have isolated a complementary DNA encoding an electrogenic Na(+)- but not Cl(-)-dependent high-affinity glutamate transporter (named EAAC1) from rabbit small intestine by expression in Xenopus oocytes. We find EAAC1 transcripts in specific neuronal structures in the central nervous system as well as in the small intestine, kidney, liver and heart. The function and pharmacology of the expressed protein are characteristic of the high-affinity glutamate transporter already identified in neuronal tissues. The abnormal glutamate transport that is associated with certain neurodegenerative diseases and which occurs during ischaemia and anoxia could be due to abnormalities in the function of this protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280334     DOI: 10.1038/360467a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  241 in total

Review 1.  Mammary gland membrane transport systems.

Authors:  D B Shennan
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

Review 2.  Role of plasma membrane transporters in muscle metabolism.

Authors:  A Zorzano; C Fandos; M Palacín
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

Review 3.  Structural features of the glutamate transporter family.

Authors:  D J Slotboom; W N Konings; J S Lolkema
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

Review 4.  High-affinity choline transporter.

Authors:  Takashi Okuda; Tatsuya Haga
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 5.  Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission.

Authors:  Arne Schousboe
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

Review 6.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.

Authors:  Jan Lewerenz; Sandra J Hewett; Ying Huang; Maria Lambros; Peter W Gout; Peter W Kalivas; Ann Massie; Ilse Smolders; Axel Methner; Mathias Pergande; Sylvia B Smith; Vadivel Ganapathy; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2012-08-03       Impact factor: 8.401

7.  Glutamate translocation of the neuronal glutamate transporter EAAC1 occurs within milliseconds.

Authors:  C Grewer; N Watzke; M Wiessner; T Rauen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

8.  A postsynaptic excitatory amino acid transporter with chloride conductance functionally regulated by neuronal activity in cerebellar Purkinje cells.

Authors:  Y Kataoka; H Morii; Y Watanabe; H Ohmori
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

9.  Treadmill pre-training suppresses the release of glutamate resulting from cerebral ischemia in rats.

Authors:  Jie Jia; Yong-Shan Hu; Yi Wu; Hui-Xian Yu; Gang Liu; Da-Nian Zhu; Chun-Mei Xia; Zhi-Juan Cao; Xi Zhang; Qing-Chuan Guo
Journal:  Exp Brain Res       Date:  2010-06-10       Impact factor: 1.972

10.  Disulfide cross-linking of transport and trimerization domains of a neuronal glutamate transporter restricts the role of the substrate to the gating of the anion conductance.

Authors:  Mustafa Shabaneh; Noa Rosental; Baruch I Kanner
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.